PD56-04 VALIDATION OF THE DECIPHER BIOPSY TEST TO PREDICT ADVERSE PATHOLOGY IN MEN DIAGNOSED WITH LOW AND FAVORABLE INTERMEDIATE RISK PROSTATE CANCER